Labgistics Asia

24/02/2026

This is the final post of the Feb Regulatory Affairs Series.

Some products move through registration quickly, while others take months. Most delays are not about the product itself, but about paperwork, planning, and knowing which regulatory route applies to you.

When teams understand timelines upfront, they can set realistic launch plans and avoid last-minute stress. If timelines are a concern, let's discuss what you are dealing with.

Drop us a DM to our inbox!

18/02/2026

If you have handled urgent temperature sensitive shipments, you know how quickly protective packaging piles up while teams rush materials straight into storage.

Across medical warehousing projects, we sees pressure from energy heavy cold storage, expiring inventory, and fragmented deliveries quietly increasing environmental impact.

Working closely with research and clinical facilities, the team finds that sustainability improves when procurement, warehouse operations, and laboratory planning are aligned earlier in supply decisions.

Scientists also share concerns that reusable packaging or shipment consolidation sometimes complicate scheduling, compliance, or contamination controls that experiments and clinical work cannot compromise.

We invite scientists, laboratory managers, and supply planners to read the article and share practical experiences balancing sustainability expectations with research and operational realities - https://labgistics.asia/sustainable-supply-chain-practices-in-medical-warehousing/

The company hopes healthcare and laboratory professionals will add perspectives on overlooked warehousing practices shaping environmental performance and supply reliability supporting daily research operations.

A closer look at how healthcare logistics in Southeast Asia and Singapore are embracing sustainable medical warehousing.

17/02/2026

A new year.
A fresh cycle.
A renewed focus on health, progress, and partnership.

As families and communities gather to welcome Chinese New Year, we at Labgistics want to wish you a season filled with clarity, strength, and prosperity. May the year ahead bring momentum to your goals and good health to everything that matters most.

🧧 Wishing you a bright and successful Chinese New Year.

From all of us at Labgistics.

09/02/2026

This is post 2 of the Feb Regulatory Affairs Series.

In Singapore, approvals are overseen by the Health Sciences Authority, and everything begins with understanding what you are registering. Medical devices are classified by risk, and that single decision determines the level of review, documentation, and approval timeline that follows.

A wheelchair and an implantable defibrillator may both be medical devices, but they are regulated in completely different ways. Class A products are exempt from full registration, while Class D devices require extensive technical and clinical evaluation. Knowing where your product sits is not a minor detail. It is the foundation of a successful submission.

If you are unsure how HSA classification affects your product or timeline, share your questions or challenges with us - https://forms.office.com/pages/responsepage.aspx?id=SIwOP8MHuEGu5hMvFi-KWnXM9k2buBtIrPnBzM5N46dUMkUzNFdSSENPU043MjEyOTlMVUFBUFZPTi4u&route=shorturl

02/02/2026

Singapore has become a trusted launchpad for medical devices, pharmaceuticals, and biologics across Southeast Asia because its regulatory process rewards preparation, accuracy, and local insight.

Before registration even begins, the right groundwork can mean the difference between smooth approval and costly delays. Singapore enables that groundwork to be built and proven early, which is why global healthcare brands see it as a strategic entry point into ASEAN.

This is post 1 of our Feb Regulatory Affairs Series, stay tuned for post 2 and 3!

28/01/2026

To welcome Chinese New Year, we surprised the team with an orange giveaway at the office. Oranges symbolize prosperity, happiness, and new beginnings, the type of energy we want to carry into this new season.

26/01/2026

Growth in logistics is often measured in larger warehouses or longer delivery routes. For us, growth is about access. Every new facility is an opportunity to serve a wider community.

Every partnership helps bring healthcare closer to those who might otherwise be left waiting. We expand responsibly by investing in people, technology, and infrastructure with one clear goal: to make healthcare accessible, safe, and timely.

Our purpose is simple, we connect life changing products with the people who need them most.

19/01/2026

If you work in Medtech, Pharma, or Biotech, this is a must-read. Singapore is not just a market entry point. It is the most efficient launchpad for regional scale, especially when supported by the right logistics and regulatory partner.

We just published a breakdown of why Singapore is the smartest first step and how Labgistics supports end-to-end readiness.

Article -

Why Singapore Is the Best Market Entry Point for Healthcare Products in ASEAN – Discover how Labgistics supports Singapore healthcare market, ASEAN medical logistics, market entry Singapore.

12/01/2026

Expanding into ASEAN markets can feel overwhelming for MedTech and pharmaceutical companies. Each country has its regulations, each application takes time, and patients often wait while approvals are pending.

We turn regulations into a bridge rather than a barrier. Our regulatory team helps manufacturers with licensing, compliance, and market entry so they can focus on science and patient care while we focus on the process.

Every successful approval means communities receive access to better healthcare sooner.

05/01/2026

Medicines and vaccines require careful handling.

They must travel across cities and borders, but they must remain in optimal condition. Cold chain logistics is one of the most complex tasks in healthcare distribution, and it is one we take personally.

We combine advanced monitoring, trained staff, and reliable infrastructure to keep products at the right temperature every step of the way. Every handover, every seal, and every reading matters because a patient’s health depends on it.